Srinivas Ayyadevara
Concepts (282)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caenorhabditis elegans | 25 | 2024 | 131 | 4.760 |
Why?
| | Alzheimer Disease | 12 | 2025 | 338 | 3.460 |
Why?
| | Neurodegenerative Diseases | 5 | 2025 | 81 | 2.550 |
Why?
| | Longevity | 12 | 2019 | 85 | 2.140 |
Why?
| | Caenorhabditis elegans Proteins | 12 | 2019 | 59 | 1.870 |
Why?
| | Aging | 5 | 2025 | 714 | 1.740 |
Why?
| | Hippocampus | 3 | 2025 | 195 | 1.380 |
Why?
| | Phosphatidylinositol 3-Kinases | 6 | 2016 | 148 | 1.230 |
Why?
| | Phosphatidylinositol Phosphates | 3 | 2018 | 17 | 1.090 |
Why?
| | Endoplasmic Reticulum Stress | 2 | 2025 | 51 | 1.010 |
Why?
| | Animals | 36 | 2025 | 13526 | 0.980 |
Why?
| | Cardiovascular Diseases | 2 | 2025 | 501 | 0.940 |
Why?
| | Aspirin | 3 | 2017 | 123 | 0.900 |
Why?
| | 14-3-3 Proteins | 2 | 2022 | 18 | 0.890 |
Why?
| | Brain | 3 | 2023 | 1350 | 0.850 |
Why?
| | Proteomics | 4 | 2025 | 336 | 0.810 |
Why?
| | Oxidative Stress | 6 | 2012 | 819 | 0.790 |
Why?
| | Creutzfeldt-Jakob Syndrome | 1 | 2022 | 6 | 0.770 |
Why?
| | Peptide Chain Elongation, Translational | 1 | 2021 | 5 | 0.690 |
Why?
| | Glutathione Transferase | 3 | 2006 | 174 | 0.690 |
Why?
| | Mitochondria | 1 | 2025 | 446 | 0.670 |
Why?
| | RNA | 1 | 2021 | 173 | 0.630 |
Why?
| | RNA Interference | 7 | 2016 | 181 | 0.620 |
Why?
| | Myocardial Infarction | 1 | 2023 | 445 | 0.610 |
Why?
| | Somatomedins | 1 | 2018 | 30 | 0.580 |
Why?
| | Mutation | 5 | 2016 | 1337 | 0.560 |
Why?
| | Membrane Proteins | 3 | 2018 | 333 | 0.560 |
Why?
| | Proteins | 2 | 2018 | 351 | 0.550 |
Why?
| | DNA | 1 | 2021 | 535 | 0.540 |
Why?
| | Phosphatidylinositol 4,5-Diphosphate | 1 | 2016 | 10 | 0.500 |
Why?
| | Muscles | 1 | 2016 | 110 | 0.490 |
Why?
| | Insulin | 1 | 2018 | 493 | 0.480 |
Why?
| | Aldehydes | 2 | 2006 | 81 | 0.480 |
Why?
| | Signal Transduction | 6 | 2025 | 1748 | 0.470 |
Why?
| | Amyloid beta-Peptides | 4 | 2021 | 65 | 0.450 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2018 | 141 | 0.440 |
Why?
| | Quantitative Trait Loci | 2 | 2006 | 53 | 0.440 |
Why?
| | Interleukin-1beta | 2 | 2025 | 88 | 0.440 |
Why?
| | Lipids | 2 | 2016 | 163 | 0.430 |
Why?
| | Chromosome Mapping | 2 | 2006 | 145 | 0.430 |
Why?
| | Humans | 27 | 2025 | 53230 | 0.420 |
Why?
| | Apolipoprotein E4 | 3 | 2025 | 23 | 0.410 |
Why?
| | Proteasome Inhibitors | 1 | 2014 | 104 | 0.410 |
Why?
| | Autophagy | 5 | 2025 | 199 | 0.410 |
Why?
| | Disease Models, Animal | 7 | 2025 | 1517 | 0.410 |
Why?
| | Mice | 9 | 2025 | 5982 | 0.370 |
Why?
| | Gene Knockdown Techniques | 3 | 2016 | 109 | 0.360 |
Why?
| | Hypertension | 1 | 2016 | 554 | 0.330 |
Why?
| | Peptide Fragments | 3 | 2021 | 209 | 0.330 |
Why?
| | Animals, Genetically Modified | 4 | 2018 | 54 | 0.330 |
Why?
| | Obesity | 1 | 2018 | 1204 | 0.320 |
Why?
| | Lipid Peroxidation | 2 | 2007 | 98 | 0.300 |
Why?
| | Gene Expression Regulation | 3 | 2011 | 1003 | 0.290 |
Why?
| | Codon, Nonsense | 3 | 2016 | 27 | 0.280 |
Why?
| | Protein Binding | 4 | 2018 | 670 | 0.280 |
Why?
| | Molecular Dynamics Simulation | 2 | 2017 | 44 | 0.240 |
Why?
| | Transcription, Genetic | 4 | 2015 | 374 | 0.240 |
Why?
| | Receptor, Insulin | 1 | 2005 | 35 | 0.230 |
Why?
| | Growth Inhibitors | 1 | 2005 | 26 | 0.230 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2025 | 17 | 0.230 |
Why?
| | Phosphorylation | 2 | 2017 | 533 | 0.230 |
Why?
| | Mitochondrial Dynamics | 1 | 2025 | 22 | 0.220 |
Why?
| | Cell Death | 2 | 2016 | 171 | 0.220 |
Why?
| | Lysosomes | 3 | 2024 | 68 | 0.220 |
Why?
| | Kidney Tubules | 2 | 2017 | 63 | 0.210 |
Why?
| | Cryoprotective Agents | 1 | 2024 | 7 | 0.210 |
Why?
| | Activating Transcription Factor 6 | 1 | 2023 | 16 | 0.210 |
Why?
| | Glioblastoma | 1 | 2025 | 101 | 0.200 |
Why?
| | Cryopreservation | 1 | 2024 | 41 | 0.200 |
Why?
| | Hydrogen Peroxide | 2 | 2016 | 121 | 0.200 |
Why?
| | Heat-Shock Proteins | 1 | 2023 | 104 | 0.200 |
Why?
| | Amino Acid Sequence | 2 | 2021 | 563 | 0.190 |
Why?
| | Exosomes | 1 | 2023 | 58 | 0.190 |
Why?
| | Male | 8 | 2025 | 27435 | 0.180 |
Why?
| | Microscopy, Fluorescence | 2 | 2012 | 140 | 0.180 |
Why?
| | Benzylamines | 1 | 2021 | 14 | 0.180 |
Why?
| | Huntington Disease | 1 | 2021 | 24 | 0.170 |
Why?
| | Cholinesterase Inhibitors | 1 | 2021 | 25 | 0.170 |
Why?
| | Brain Neoplasms | 1 | 2025 | 319 | 0.170 |
Why?
| | Alkaloids | 1 | 2021 | 34 | 0.170 |
Why?
| | Protein Folding | 1 | 2021 | 60 | 0.170 |
Why?
| | Indoles | 2 | 2020 | 280 | 0.170 |
Why?
| | Oxyquinoline | 1 | 2020 | 8 | 0.160 |
Why?
| | Myocardium | 1 | 2023 | 471 | 0.160 |
Why?
| | RNA, Viral | 1 | 2021 | 123 | 0.160 |
Why?
| | Chelating Agents | 1 | 2020 | 31 | 0.160 |
Why?
| | Neuroprotective Agents | 1 | 2021 | 101 | 0.160 |
Why?
| | Mice, Inbred C57BL | 2 | 2023 | 1925 | 0.160 |
Why?
| | Glioma | 1 | 2021 | 83 | 0.160 |
Why?
| | RNA-Binding Proteins | 1 | 2021 | 133 | 0.160 |
Why?
| | Drug Design | 1 | 2020 | 121 | 0.160 |
Why?
| | Proteome | 1 | 2021 | 177 | 0.150 |
Why?
| | Aged | 3 | 2025 | 10429 | 0.150 |
Why?
| | Models, Animal | 3 | 2019 | 233 | 0.150 |
Why?
| | Computer Simulation | 2 | 2017 | 290 | 0.150 |
Why?
| | Hot Temperature | 2 | 2012 | 202 | 0.150 |
Why?
| | Ubiquitin | 2 | 2018 | 70 | 0.140 |
Why?
| | Cells, Cultured | 4 | 2016 | 1569 | 0.140 |
Why?
| | DNA-Binding Proteins | 1 | 2021 | 423 | 0.140 |
Why?
| | Gene Regulatory Networks | 1 | 2019 | 112 | 0.140 |
Why?
| | Cell Line | 2 | 2018 | 1016 | 0.140 |
Why?
| | Forkhead Transcription Factors | 3 | 2009 | 120 | 0.140 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2018 | 136 | 0.140 |
Why?
| | Nucleotide Motifs | 1 | 2017 | 22 | 0.130 |
Why?
| | Replication Origin | 1 | 2017 | 11 | 0.130 |
Why?
| | RNA, Transfer | 1 | 2017 | 13 | 0.130 |
Why?
| | Telomerase | 1 | 2017 | 26 | 0.130 |
Why?
| | Acetylation | 1 | 2017 | 97 | 0.130 |
Why?
| | Mice, Transgenic | 1 | 2018 | 561 | 0.130 |
Why?
| | Complement C1q | 1 | 2017 | 6 | 0.130 |
Why?
| | Pericytes | 1 | 2017 | 13 | 0.130 |
Why?
| | Complement C3 | 1 | 2017 | 20 | 0.130 |
Why?
| | Complement Activation | 1 | 2017 | 27 | 0.130 |
Why?
| | Carrier Proteins | 1 | 2018 | 315 | 0.130 |
Why?
| | Intermediate Filament Proteins | 1 | 2016 | 12 | 0.130 |
Why?
| | Detergents | 1 | 2016 | 15 | 0.120 |
Why?
| | Thermodynamics | 1 | 2016 | 34 | 0.120 |
Why?
| | tau Proteins | 1 | 2016 | 25 | 0.120 |
Why?
| | Promoter Regions, Genetic | 2 | 2011 | 465 | 0.120 |
Why?
| | DNA, Mitochondrial | 1 | 2017 | 116 | 0.120 |
Why?
| | Catalytic Domain | 1 | 2016 | 60 | 0.120 |
Why?
| | Transcriptome | 1 | 2019 | 367 | 0.120 |
Why?
| | Young Adult | 2 | 2016 | 4511 | 0.120 |
Why?
| | DNA Replication | 1 | 2017 | 161 | 0.120 |
Why?
| | Blotting, Western | 2 | 2014 | 587 | 0.120 |
Why?
| | Solubility | 1 | 2016 | 83 | 0.120 |
Why?
| | Pyridinium Compounds | 1 | 2015 | 20 | 0.120 |
Why?
| | Ligands | 1 | 2016 | 203 | 0.120 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2015 | 26 | 0.120 |
Why?
| | Tissue Distribution | 1 | 2016 | 174 | 0.120 |
Why?
| | Myofibroblasts | 1 | 2016 | 50 | 0.120 |
Why?
| | Homologous Recombination | 1 | 2015 | 45 | 0.120 |
Why?
| | Benzimidazoles | 1 | 2015 | 50 | 0.120 |
Why?
| | Reference Values | 1 | 2016 | 311 | 0.120 |
Why?
| | Peptide Nucleic Acids | 1 | 2015 | 18 | 0.110 |
Why?
| | Antineoplastic Agents | 2 | 2015 | 1232 | 0.110 |
Why?
| | Rad51 Recombinase | 1 | 2015 | 29 | 0.110 |
Why?
| | Transcription Factors | 3 | 2009 | 571 | 0.110 |
Why?
| | Fluorescent Antibody Technique | 1 | 2014 | 109 | 0.110 |
Why?
| | Fertility | 1 | 2014 | 32 | 0.110 |
Why?
| | Cell Proliferation | 2 | 2025 | 1031 | 0.110 |
Why?
| | Protein Multimerization | 1 | 2014 | 57 | 0.110 |
Why?
| | Stress, Physiological | 3 | 2011 | 184 | 0.110 |
Why?
| | Aged, 80 and over | 2 | 2025 | 3494 | 0.110 |
Why?
| | Melphalan | 1 | 2015 | 180 | 0.110 |
Why?
| | Kidney | 2 | 2024 | 715 | 0.100 |
Why?
| | Macrophages | 1 | 2017 | 380 | 0.100 |
Why?
| | Cell Line, Tumor | 4 | 2025 | 1470 | 0.100 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2017 | 205 | 0.100 |
Why?
| | Models, Molecular | 3 | 2020 | 352 | 0.100 |
Why?
| | Case-Control Studies | 1 | 2016 | 1212 | 0.100 |
Why?
| | Recombinant Fusion Proteins | 2 | 2021 | 175 | 0.100 |
Why?
| | Age Factors | 1 | 2016 | 1136 | 0.090 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2015 | 350 | 0.090 |
Why?
| | Life Expectancy | 1 | 2012 | 35 | 0.090 |
Why?
| | Lipoprotein Lipase | 1 | 2012 | 14 | 0.090 |
Why?
| | Locomotion | 1 | 2012 | 79 | 0.090 |
Why?
| | Endothelial Cells | 2 | 2011 | 289 | 0.090 |
Why?
| | Microscopy, Confocal | 1 | 2012 | 75 | 0.090 |
Why?
| | Scavenger Receptors, Class E | 2 | 2011 | 204 | 0.090 |
Why?
| | Fluorescent Dyes | 1 | 2012 | 90 | 0.090 |
Why?
| | Down-Regulation | 2 | 2011 | 344 | 0.090 |
Why?
| | Data Mining | 1 | 2011 | 44 | 0.090 |
Why?
| | Triglycerides | 1 | 2012 | 171 | 0.090 |
Why?
| | Antimitotic Agents | 1 | 2010 | 4 | 0.080 |
Why?
| | Oxidants | 1 | 2011 | 51 | 0.080 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2011 | 85 | 0.080 |
Why?
| | Multiple Myeloma | 2 | 2015 | 3082 | 0.080 |
Why?
| | Cisplatin | 1 | 2012 | 282 | 0.080 |
Why?
| | Fatty Acids | 1 | 2011 | 154 | 0.080 |
Why?
| | Adult | 2 | 2016 | 14534 | 0.080 |
Why?
| | Female | 4 | 2025 | 28782 | 0.080 |
Why?
| | Histoplasma | 1 | 2009 | 24 | 0.080 |
Why?
| | Lipoproteins, LDL | 1 | 2011 | 175 | 0.080 |
Why?
| | Angiogenesis Inhibitors | 1 | 2010 | 186 | 0.080 |
Why?
| | Histoplasmosis | 1 | 2009 | 48 | 0.070 |
Why?
| | Alleles | 1 | 2009 | 277 | 0.070 |
Why?
| | Evolution, Molecular | 1 | 2009 | 97 | 0.070 |
Why?
| | Gene Expression | 2 | 2012 | 618 | 0.070 |
Why?
| | Atherosclerosis | 1 | 2011 | 224 | 0.070 |
Why?
| | Binding Sites | 1 | 2009 | 373 | 0.070 |
Why?
| | Survival Rate | 1 | 2011 | 949 | 0.070 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2009 | 412 | 0.070 |
Why?
| | Oxygen | 1 | 2010 | 338 | 0.070 |
Why?
| | Oogenesis | 1 | 2007 | 19 | 0.070 |
Why?
| | Acute Kidney Injury | 1 | 2012 | 399 | 0.070 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2007 | 147 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2021 | 1367 | 0.060 |
Why?
| | DNA Methylation | 1 | 2011 | 592 | 0.060 |
Why?
| | Genes, Helminth | 1 | 2006 | 4 | 0.060 |
Why?
| | Genes, Insect | 1 | 2006 | 11 | 0.060 |
Why?
| | Drosophila melanogaster | 1 | 2006 | 32 | 0.060 |
Why?
| | Models, Biological | 1 | 2009 | 737 | 0.060 |
Why?
| | Environment | 1 | 2006 | 87 | 0.060 |
Why?
| | Apoptosis | 1 | 2011 | 1139 | 0.060 |
Why?
| | Neurofibrillary Tangles | 1 | 2025 | 6 | 0.060 |
Why?
| | Genotype | 2 | 2017 | 563 | 0.060 |
Why?
| | Isoenzymes | 1 | 2005 | 165 | 0.060 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2015 | 228 | 0.060 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2005 | 180 | 0.050 |
Why?
| | Stress, Psychological | 1 | 2006 | 282 | 0.050 |
Why?
| | Hormesis | 1 | 2024 | 10 | 0.050 |
Why?
| | Vitrification | 1 | 2024 | 5 | 0.050 |
Why?
| | Cytokines | 2 | 2017 | 627 | 0.050 |
Why?
| | Disease Progression | 2 | 2017 | 880 | 0.050 |
Why?
| | Animals, Congenic | 1 | 2003 | 3 | 0.050 |
Why?
| | Animals, Inbred Strains | 1 | 2003 | 5 | 0.050 |
Why?
| | Saccharomyces cerevisiae | 1 | 2024 | 166 | 0.050 |
Why?
| | Genetic Markers | 1 | 2003 | 104 | 0.050 |
Why?
| | Cell Survival | 2 | 2015 | 600 | 0.050 |
Why?
| | Electrophorus | 1 | 2021 | 5 | 0.040 |
Why?
| | Time Factors | 2 | 2019 | 2991 | 0.040 |
Why?
| | Butyrylcholinesterase | 1 | 2021 | 9 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2017 | 1133 | 0.040 |
Why?
| | Lasers | 1 | 2021 | 64 | 0.040 |
Why?
| | Acetylcholinesterase | 1 | 2021 | 21 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2015 | 868 | 0.040 |
Why?
| | Horses | 1 | 2021 | 49 | 0.040 |
Why?
| | Phenotype | 2 | 2017 | 803 | 0.040 |
Why?
| | Middle Aged | 1 | 2016 | 13419 | 0.040 |
Why?
| | Biological Assay | 1 | 2021 | 46 | 0.040 |
Why?
| | Chemistry Techniques, Synthetic | 1 | 2020 | 21 | 0.040 |
Why?
| | Molecular Structure | 1 | 2021 | 320 | 0.040 |
Why?
| | Protein Structure, Secondary | 1 | 2020 | 71 | 0.040 |
Why?
| | Peptides | 1 | 2021 | 234 | 0.040 |
Why?
| | Structure-Activity Relationship | 1 | 2021 | 396 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2020 | 235 | 0.040 |
Why?
| | Dipyrone | 1 | 2019 | 2 | 0.040 |
Why?
| | Anisomycin | 1 | 2019 | 3 | 0.040 |
Why?
| | Camptothecin | 1 | 2019 | 14 | 0.040 |
Why?
| | Benzazepines | 1 | 2019 | 20 | 0.040 |
Why?
| | Azacitidine | 1 | 2019 | 39 | 0.040 |
Why?
| | Protein Unfolding | 1 | 2018 | 7 | 0.040 |
Why?
| | Protein Conformation | 1 | 2018 | 174 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2019 | 487 | 0.030 |
Why?
| | Apolipoprotein E3 | 1 | 2017 | 9 | 0.030 |
Why?
| | Epistasis, Genetic | 1 | 2017 | 27 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 18 | 0.030 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2017 | 71 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2017 | 73 | 0.030 |
Why?
| | Molecular Docking Simulation | 1 | 2017 | 93 | 0.030 |
Why?
| | Wnt3A Protein | 1 | 2017 | 12 | 0.030 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2017 | 19 | 0.030 |
Why?
| | Extracellular Matrix Proteins | 1 | 2017 | 69 | 0.030 |
Why?
| | Cell Communication | 1 | 2017 | 73 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2017 | 115 | 0.030 |
Why?
| | Ureteral Obstruction | 1 | 2017 | 62 | 0.030 |
Why?
| | Indolizines | 1 | 2015 | 5 | 0.030 |
Why?
| | Fibrosis | 1 | 2017 | 198 | 0.030 |
Why?
| | Cyclic N-Oxides | 1 | 2015 | 12 | 0.030 |
Why?
| | Folic Acid | 1 | 2017 | 137 | 0.030 |
Why?
| | Wnt Signaling Pathway | 1 | 2017 | 98 | 0.030 |
Why?
| | Drug Synergism | 1 | 2015 | 147 | 0.030 |
Why?
| | Mice, SCID | 1 | 2015 | 180 | 0.030 |
Why?
| | S Phase | 1 | 2015 | 20 | 0.030 |
Why?
| | Genes, BRCA1 | 1 | 2015 | 19 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2017 | 910 | 0.030 |
Why?
| | DNA Damage | 1 | 2015 | 309 | 0.020 |
Why?
| | Receptors, Lipoprotein | 1 | 2012 | 7 | 0.020 |
Why?
| | Azo Compounds | 1 | 2012 | 11 | 0.020 |
Why?
| | Angiopoietins | 1 | 2012 | 6 | 0.020 |
Why?
| | Peroxisome Proliferator-Activated Receptors | 1 | 2012 | 16 | 0.020 |
Why?
| | Neutrophil Infiltration | 1 | 2012 | 25 | 0.020 |
Why?
| | Coloring Agents | 1 | 2012 | 65 | 0.020 |
Why?
| | Intracellular Space | 1 | 2012 | 24 | 0.020 |
Why?
| | Adipose Tissue, White | 1 | 2012 | 35 | 0.020 |
Why?
| | Melanins | 1 | 2012 | 20 | 0.020 |
Why?
| | Necrosis | 1 | 2012 | 169 | 0.020 |
Why?
| | Imaging, Three-Dimensional | 1 | 2012 | 145 | 0.020 |
Why?
| | Intercellular Junctions | 1 | 2010 | 7 | 0.020 |
Why?
| | Antibodies, Neutralizing | 1 | 2011 | 78 | 0.020 |
Why?
| | Cell Hypoxia | 1 | 2010 | 82 | 0.020 |
Why?
| | Body Weight | 1 | 2012 | 524 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 547 | 0.020 |
Why?
| | Up-Regulation | 1 | 2011 | 456 | 0.020 |
Why?
| | Microscopy | 1 | 2009 | 47 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1043 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2012 | 681 | 0.020 |
Why?
| | Virulence | 1 | 2009 | 163 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2009 | 135 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1112 | 0.020 |
Why?
| | Liver | 1 | 2012 | 1150 | 0.020 |
Why?
|
|
Ayyadevara's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|